NANOVIRICIDES, INC.

Insiders NanoViricides, Inc.

Equities

NNVC

US6300873022

Market Closed - Nyse Other stock markets 04:00:00 2024-05-06 pm EDT			5-day change	1st Jan Change
1.4 ^USD	+23.89%		+23.89%	+37.25%

Apr. 30	NanoViricides, Inc. Reports That the Phase I NV-387 Clinical Trial Is Completed Successfully and Data Lock Is Expected Soon	CI
Feb. 14	NanoViricides, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nanoviricides, Inc. Announces Board Changes	20-11-19	CI
NanoViricides, Inc. Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19	20-09-15	CI
Nanoviricides, Inc. Announces Resignation of Mark Day from the Board	20-06-04	CI
NanoViricides, Inc Appoints Todd Rokita as A New Member of the Board and Also to the Board’s Nomination Committee and Compensation Committee	20-05-19	CI
NanoViricides, Inc Announces Executive Changes	20-02-11	CI
Nanoviricides, Inc. Announces Resignation of Mukund Kulkarni as Member of the Board of Directors and Member of Audit, Nominating and Compensation Committees	19-08-01	CI
NanoViricides, Inc. Appoints Mark Day as New Member of the Board	19-06-10	CI
NanoViricides, Inc. Announces Resignation of Irach Taraporewala as the Chief Executive Officer	19-02-01	CI
NanoViricides, Inc. Announces Board and Committee Appointments	18-10-29	CI
NanoViricides, Inc. Announces Resignation of Milton Boniuk as Director and as a Member of Audit, Compensation and Nominating Committees	18-09-12	CI
NanoViricides, Inc. Appoints Irach Taraporewala as the New CEO and Nominates to Serve as a Member of the Board of Directors	18-07-23	CI
NanoViricides, Inc. Announces Executive Changes	18-07-11	CI
NanoViricides, Inc. Announces Resignation of Eugene Seymour as Chief Executive Officer and Director	18-05-04	CI
NanoViricides, Inc. Announces Management Changes	18-02-21	CI
NanoViricides, Inc. Appoints Mukund S Kulkarni as an Independent Board Member	13-06-24	CI
NanoViricides, Inc. Appoints Milton Boniuk as Independent Board Member	13-05-28	CI
NanoViricides Appoints Meeta Vyas as an Interim CFO	13-05-13	CI
NanoViricides, Inc. Appoints Stanley Glick as a Director and Chairman of the Audit Committee	12-06-25	CI
NanoViricides, Inc. Appoints Andrew Hahn as Consultant for Design and Construction of Pilot cGMP Production Facility	12-05-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW